M. Kiełbiński

发表

Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential

A. Kutner, E. Marcinkowska, Elżbieta Gocek, 2008, Steroids.

Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.

W. Jędrzejczak, K. Sułek, T. Robak, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Status of minimal residual disease after induction predicts outcome in both standard and high‐risk Ph‐negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4‐2002 MRD Study

W. Jędrzejczak, I. Seferyńska, A. Skotnicki, 2008, British journal of haematology.

Variations in Suppressor Molecule CTLA-4 Gene Are Related to Susceptibility to Multiple Myeloma in a Polish Population

K. Kuliczkowski, L. Karabon, I. Frydecka, 2011, Pathology & Oncology Research.

The soluble CTLA-4 receptor: a new marker in autoimmune diseases.

I. Frydecka, I. Kochanowska, S. Potoczek, 2005, Archivum immunologiae et therapiae experimentalis.

31P MRS analysis of the phospholipid composition of the peripheral blood mononuclear cells (PBMC) and bone marrow mononuclear cells (BMMC) of patients with acute leukemia (AL)

B. Jaźwiec, M. Kiełbiński, M. Kuliszkiewicz-Janus, 2008, Cellular & Molecular Biology Letters.

The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; The results of multicenter, prospective Polish adult leukemia group study

K. Kuliczkowski, A. Wierzbowska, A. Skotnicki, 2011, American journal of hematology.

KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.

K. Kuliczkowski, L. Karabon, I. Frydecka, 2011, Tissue antigens.

MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients

D. Duś, K. Kuliczkowski, J. Rossowska, 2017, European journal of haematology.

ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population.

K. Kuliczkowski, L. Karabon, I. Frydecka, 2011, Folia histochemica et cytobiologica.

Structure–function analysis of vitamin D2 analogs as potential inducers of leukemia differentiation and inhibitors of prostate cancer proliferation

A. Kutner, A. Klopot, E. Marcinkowska, 2011, The Journal of Steroid Biochemistry and Molecular Biology.

Monocytic differentiation induced by side-chain modified analogs of vitamin D in ex vivo cells from patients with acute myeloid leukemia.

A. Kutner, P. Biecek, E. Marcinkowska, 2014, Leukemia research.

Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG).

W. Jędrzejczak, K. Sułek, T. Robak, 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Different susceptibilities to 1,25-dihydroxyvitamin D3-induced differentiation of AML cells carrying various mutations.

A. Kutner, E. Marcinkowska, O. Haus, 2010, Leukemia research.

Effect of tungsten content on the properties and structure of cold extruded Cu-W composite materials

K. Kainer, B. Mordike, J. Kaczmar, 1991 .

Acute iron poisoning in adult female

Marceli Lukaszewski, A. Skoczyńska, M. Kiełbiński, 2007, Human & experimental toxicology.

Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML.

M. Czyżewska, J. Czyż, K. Kuliczkowski, 2018, Leukemia research.

Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G‐CSF (CLAG‐M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group

T. Robak, K. Kuliczkowski, A. Wierzbowska, 2007, European journal of haematology.

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

W. Jędrzejczak, K. Sułek, T. Robak, 2004, Leukemia.

Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation

E. Marcinkowska, Elżbieta Gocek, M. Kiełbiński, 2007, FEBS letters.

CEBPA copy number variations in normal karyotype acute myeloid leukemia: Possible role of breakpoint-associated microhomology and chromatin status in CEBPA mutagenesis.

K. Kuliczkowski, A. Skotnicki, K. Warzocha, 2015, Blood cells, molecules & diseases.

Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients.

W. Jędrzejczak, K. Kuliczkowski, A. Wierzbowska, 2016, Blood.

Platelet-activating factor changes in phospholipid extracts from the plasma, peripheral blood mononuclear cells and bone marrow mononuclear cells of patients with acute leukemia — A 31P MRS in vitro study

B. Jaźwiec, M. Kiełbiński, M. Kuliszkiewicz-Janus, 2007, Cellular & Molecular Biology Letters.

Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.

K. Kuliczkowski, L. Karabon, I. Frydecka, 2015, Tissue antigens.

KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.

K. Kuliczkowski, L. Karabon, I. Frydecka, 2011, Tissue antigens.

Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.

L. Karabon, P. Kuśnierczyk, D. Woszczyk, 2015, Tissue antigens.

W. Jędrzejczak, I. Seferyńska, A. Skotnicki, 2008, British journal of haematology.